刺槐素
TL;DR: 刺槐素 (CAS 80443-15-8) is a chemical compound with molecular formula C16H12O5 and molecular weight 284.07 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
刺槐素
5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one
Also Known As: acacetin, Linarigenin, Buddleoflavonol, Linarisenin, Acacetine
| Molecular Formula | C16H12O5 |
|---|---|
| Molecular Weight | 284.07 g/mol |
| LogP | 2.8798 |
| Topological Polar Surface Area | 79.9 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Exact Mass | 284.06848 |
| Heavy Atoms | 21 |
| Complexity | 862.21 |
Chemical Identifiers
| CAS Number | 80443-15-8 |
|---|---|
| SMILES | COC1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O |
Product Overview
刺槐素 (CAS 80443-15-8), with molecular formula C16H12O5 and molecular weight 284.07 g/mol. IUPAC: 5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one.
Chemical Property Profile of 刺槐素
Property Insights of 刺槐素
The XLogP value of 2.8798 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 刺槐素. The TPSA of 79.9 Ų falls within the moderate polarity range, balancing permeability and solubility for 刺槐素. Following Lipinski's Rule of Five, 刺槐素 has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 刺槐素?
The CAS number of 刺槐素 is 80443-15-8.
What is the molecular formula of 刺槐素?
The molecular formula of 刺槐素 is C16H12O5.
What is the molecular weight of 刺槐素?
The molecular weight of 刺槐素 is 284.07 g/mol.
Where can I buy 刺槐素?
You can request a quote for 刺槐素 directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 刺槐素?
Yes, KEHONG BIO provides custom synthesis services for 刺槐素 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.